IBDEI1KZ ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,28059,2)
 ;;=^123801
 ;;^UTILITY(U,$J,358.3,28060,0)
 ;;=281.0^^162^1791^121
 ;;^UTILITY(U,$J,358.3,28060,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28060,1,4,0)
 ;;=4^281.0
 ;;^UTILITY(U,$J,358.3,28060,1,5,0)
 ;;=5^Vit B12 Deficiency (Pernicious Anemia)
 ;;^UTILITY(U,$J,358.3,28060,2)
 ;;=^7161
 ;;^UTILITY(U,$J,358.3,28061,0)
 ;;=282.60^^162^1791^109
 ;;^UTILITY(U,$J,358.3,28061,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28061,1,4,0)
 ;;=4^282.60
 ;;^UTILITY(U,$J,358.3,28061,1,5,0)
 ;;=5^Sickle-Cell Anemia
 ;;^UTILITY(U,$J,358.3,28061,2)
 ;;=^7188
 ;;^UTILITY(U,$J,358.3,28062,0)
 ;;=282.62^^162^1791^110
 ;;^UTILITY(U,$J,358.3,28062,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28062,1,4,0)
 ;;=4^282.62
 ;;^UTILITY(U,$J,358.3,28062,1,5,0)
 ;;=5^Sickle-Cell w/ Crisis
 ;;^UTILITY(U,$J,358.3,28062,2)
 ;;=^267982
 ;;^UTILITY(U,$J,358.3,28063,0)
 ;;=281.1^^162^1791^120
 ;;^UTILITY(U,$J,358.3,28063,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28063,1,4,0)
 ;;=4^281.1
 ;;^UTILITY(U,$J,358.3,28063,1,5,0)
 ;;=5^Vit B12 Deficiency (Dietary)
 ;;^UTILITY(U,$J,358.3,28063,2)
 ;;=^267974
 ;;^UTILITY(U,$J,358.3,28064,0)
 ;;=286.7^^162^1791^52
 ;;^UTILITY(U,$J,358.3,28064,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28064,1,4,0)
 ;;=4^286.7
 ;;^UTILITY(U,$J,358.3,28064,1,5,0)
 ;;=5^Coagulation Defect(Any),Acquired
 ;;^UTILITY(U,$J,358.3,28064,2)
 ;;=^2235
 ;;^UTILITY(U,$J,358.3,28065,0)
 ;;=289.9^^162^1791^117
 ;;^UTILITY(U,$J,358.3,28065,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28065,1,4,0)
 ;;=4^289.9
 ;;^UTILITY(U,$J,358.3,28065,1,5,0)
 ;;=5^Thrombocytosis, Essential
 ;;^UTILITY(U,$J,358.3,28065,2)
 ;;=^55344
 ;;^UTILITY(U,$J,358.3,28066,0)
 ;;=451.9^^162^1791^118
 ;;^UTILITY(U,$J,358.3,28066,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28066,1,4,0)
 ;;=4^451.9
 ;;^UTILITY(U,$J,358.3,28066,1,5,0)
 ;;=5^Thrombophlebitis 
 ;;^UTILITY(U,$J,358.3,28066,2)
 ;;=^93357
 ;;^UTILITY(U,$J,358.3,28067,0)
 ;;=446.6^^162^1791^119
 ;;^UTILITY(U,$J,358.3,28067,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28067,1,4,0)
 ;;=4^446.6
 ;;^UTILITY(U,$J,358.3,28067,1,5,0)
 ;;=5^Thrombotic Thrombocytopenic Purpura(TTP)
 ;;^UTILITY(U,$J,358.3,28067,2)
 ;;=^119061
 ;;^UTILITY(U,$J,358.3,28068,0)
 ;;=286.4^^162^1791^122
 ;;^UTILITY(U,$J,358.3,28068,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28068,1,4,0)
 ;;=4^286.4
 ;;^UTILITY(U,$J,358.3,28068,1,5,0)
 ;;=5^Von Willebrand's Disease
 ;;^UTILITY(U,$J,358.3,28068,2)
 ;;=^127267
 ;;^UTILITY(U,$J,358.3,28069,0)
 ;;=204.00^^162^1791^1
 ;;^UTILITY(U,$J,358.3,28069,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28069,1,4,0)
 ;;=4^204.00
 ;;^UTILITY(U,$J,358.3,28069,1,5,0)
 ;;=5^ALL w/o Remission
 ;;^UTILITY(U,$J,358.3,28069,2)
 ;;=^267521
 ;;^UTILITY(U,$J,358.3,28070,0)
 ;;=204.01^^162^1791^3
 ;;^UTILITY(U,$J,358.3,28070,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28070,1,4,0)
 ;;=4^204.01
 ;;^UTILITY(U,$J,358.3,28070,1,5,0)
 ;;=5^ALL, In Remission
 ;;^UTILITY(U,$J,358.3,28070,2)
 ;;=^267522
 ;;^UTILITY(U,$J,358.3,28071,0)
 ;;=204.10^^162^1791^46
 ;;^UTILITY(U,$J,358.3,28071,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28071,1,4,0)
 ;;=4^204.10
 ;;^UTILITY(U,$J,358.3,28071,1,5,0)
 ;;=5^CLL w/o Remission
 ;;^UTILITY(U,$J,358.3,28071,2)
 ;;=^267523
 ;;^UTILITY(U,$J,358.3,28072,0)
 ;;=204.11^^162^1791^47
 ;;^UTILITY(U,$J,358.3,28072,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28072,1,4,0)
 ;;=4^204.11
 ;;^UTILITY(U,$J,358.3,28072,1,5,0)
 ;;=5^CLL, In Remission
 ;;^UTILITY(U,$J,358.3,28072,2)
 ;;=^267524
 ;;^UTILITY(U,$J,358.3,28073,0)
 ;;=202.41^^162^1791^74
 ;;^UTILITY(U,$J,358.3,28073,1,0)
 ;;=^358.31IA^5^2
 ;;
 ;;$END ROU IBDEI1KZ
